IGFBP5
Insulin-like growth factor-binding protein 5
Also known as: IBP5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P24593
- Gene
- IGFBP5
- Ensembl
- ENSG00000115461
- Chromosome
- 2
- Canonical length
- 272 aa
- Protein class
- Plasma proteins, Predicted secreted proteins
- Subcellular location
- Vesicles
- Secretome location
- Secreted to blood
OverviewNCBI Gene
Enables insulin-like growth factor I binding activity and receptor ligand activity. Involved in several processes, including cellular response to cAMP; regulation of smooth muscle cell migration; and regulation of smooth muscle cell proliferation. Part of insulin-like growth factor ternary complex. Biomarker of pulmonary fibrosis. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
272 residues, UniProt reviewed canonical sequence.
>P24593|IGFBP5
1 MVLLTAVLLL LAAYAGPAQS LGSFVHCEPC DEKALSMCPP SPLGCELVKE PGCGCCMTCA
61 LAEGQSCGVY TERCAQGLRC LPRQDEEKPL HALLHGRGVC LNEKSYREQV KIERDSREHE
121 EPTTSEMAEE TYSPKIFRPK HTRISELKAE AVKKDRRKKL TQSKFVGGAE NTAHPRIISA
181 PEMRQESEQG PCRRHMEASL QELKASPRMV PRAVYLPNCD RKGFYKRKQC KPSRGRKRGI
241 CWCVDKYGMK LPGMEYVDGD FQCHTFDSSN VELocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGFBP5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 1,401 nTPM
Expression across tissuesHPA
Tissue
- cervix: 1,401 nTPM
- ovary: 1,167 nTPM
- fallopian tube: 929 nTPM
- endometrium: 851 nTPM
- smooth muscle: 581 nTPM
- kidney: 466 nTPM
Single-cell type
- medullary thymic epithelial cells: 4,066 nCPM
- decidual stromal cells: 3,181 nCPM
- ovarian stromal cells: 2,470 nCPM
- fibroblasts: 1,932 nCPM
- pericytes: 1,809 nCPM
- vascular smooth muscle cells: 1,620 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 131 nTPM
- hippocampal formation: 109 nTPM
- choroid plexus: 103 nTPM
- hypothalamus: 96 nTPM
- midbrain: 86 nTPM
- medulla oblongata: 82 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.29
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 1.63
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell population proliferation
- cellular response to cAMP
- female pregnancy
- glucose homeostasis
- hair follicle morphogenesis
- insulin-like growth factor receptor signaling pathway
- intracellular signal transduction
- lung alveolus development
- mammary gland involution
- negative regulation of cell migration
- negative regulation of growth
- negative regulation of insulin-like growth factor receptor signaling pathway
- negative regulation of osteoblast differentiation
- negative regulation of smooth muscle cell migration
- negative regulation of smooth muscle cell proliferation
- negative regulation of translation
- osteoblast differentiation
- positive regulation of insulin-like growth factor receptor signaling pathway
- positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- positive regulation of vascular associated smooth muscle cell migration
- positive regulation of vascular associated smooth muscle cell proliferation
- regulation of cell growth
- regulation of insulin-like growth factor receptor signaling pathway
- response to growth hormone
- signal transduction
- striated muscle cell differentiation
- type B pancreatic cell proliferation
- negative regulation of muscle tissue development
- negative regulation of skeletal muscle hypertrophy
Molecular functions
- fibronectin binding
- insulin-like growth factor I binding
- insulin-like growth factor II binding
- receptor ligand activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Thyroglobulin type-1
- Insulin-like growth factor-binding protein, IGFBP
- Growth factor receptor cysteine-rich domain superfamily
- Insulin-like growth factor binding protein, N-terminal, Cys-rich conserved site
- Insulin-like growth factor-binding protein family 1-6, chordata
- Thyroglobulin type-1 superfamily
- Thyroglobulin type-1 repeat
- Insulin-like growth factor binding protein
- Insulin-like growth factor binding protein 5
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IGFBP5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGFBP5 as an antibody target. Whether an autoantibody or antibody against IGFBP5 could matter depends on whether native IGFBP5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGFBP5 is annotated as secreted, so native IGFBP5 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IGFBP5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...